+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BIOGEN BIOGEN

Biogen Pharmachem Industries Share Price

 
Near 52W Low of ₹0.27

07 Aug, 2026 4:00 PM (IST)

Biogen Pharmachem Industries live price: ₹0.28.

Biogen Pharmachem Industries Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹1
  • Open Price₹0
  • Previous Close₹0
  • Volume2,500,585
  • 50 DMA₹0.30
  • 100 DMA₹0.40
  • 200 DMA₹0.50

Biogen Pharmachem Industries Chart

Investment Returns

  • Over 1 Month -9.68%
  • Over 3 Month -31.71%
  • Over 6 Month -52.54%
  • Over 1 Year -64.56%

Smart Investing Starts Here Start SIP with Biogen Pharmachem Industries for Steady Growth!

Invest Now

Biogen Pharmachem Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -177.2
  • PEG Ratio
  • 1.6
  • Market Cap Cr
  • 30
  • P/B Ratio
  • 0.3
  • Average True Range
  • 0.02
  • EPS
  • -0
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 37.08
  • MFI
  • 19.4

Latest Stock News Updates

Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

PFA

Biogen Pharmachem Industries Ltd - 531752 - Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

PFA

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 5th August,2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2026. The board meeting commented at 03:15 PM and concluded at 03:35 PM Please take the above intimation in your records. Thanking You.

Biogen Pharmachem Industries Financials

Biogen Pharmachem Industries Technicals

EMA & SMA

Current Price
₹0.28
-0.01 (-3.45%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹0.30
  • 50 Day
  • ₹0.30
  • 100 Day
  • ₹0.40
  • 200 Day
  • ₹0.50

Resistance and Support

0.29 Pivot Speed
  • R3 0.30
  • R2 0.30
  • R1 0.30
  • S1 0.30
  • S2 0.30
  • S3 0.30

Biogen Pharmachem Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-05 Quarterly Results
2026-05-14 Audited Results
2026-03-23 Bonus issue
2026-02-11 Quarterly Results (Revised)
2025-11-07 Quarterly Results
Date Purpose Remarks
2003-07-21 Split Face value changed from Rs. 10/- to Rs. 1/-
Date Purpose Remarks
2026-05-15 Bonus Bonus issue of equity shares in the ratio of 1:6 of Re. 1/-..

Biogen Pharmachem Industries Shareholding Pattern

100%
0%
0%

About Biogen Pharmachem Industries

Biogen Pharmachem Industries is engaged in the financial services sector, including trading in shares, securities, and commodities. View More
  • NSE Symbol
  • BIOGEN
  • BSE Symbol
  • 531752
  • ISIN
  • INE703D01023

Similar Stocks to Biogen Pharmachem Industries

Biogen Pharmachem Industries FAQs

Biogen Pharmachem Industries share price is ₹0 As on 08 August, 2026 | 08:54

The Market Cap of Biogen Pharmachem Industries is ₹29.5 Cr As on 08 August, 2026 | 08:54

The P/E ratio of Biogen Pharmachem Industries is -177.2 As on 08 August, 2026 | 08:54

The PB ratio of Biogen Pharmachem Industries is 0.3 As on 08 August, 2026 | 08:54

The 52 week High & Low of Biogen Pharmachem Industries is ₹0.8/₹0.3 respectively As on 08 August, 2026 | 08:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23